Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781388 · ClinicalTrials.gov registry record · Phase 4
ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT03781388 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 45 participants.
The verdict
NCT03781388, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.
Interventions
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2022-12-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03781388
The ClinicalTrials.gov registry entry for NCT03781388 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine is the first listed.
NCT03781388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03781388 about?
NCT03781388 is a clinical study titled "ED90 for Hyperbaric Bupivacaine in Super Obese Parturients". The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.
What is the current status of trial NCT03781388?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2019-05-01. Estimated completion is 2022-12-06.
What interventions are being tested in trial NCT03781388?
The interventions under investigation include: Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03781388?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.